🇺🇸 FDA
Patent

US 11976299

Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same

granted A61KA61K40/19A61K40/24

Quick answer

US patent 11976299 (Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K40/19, A61K40/24, A61K40/4201, A61K40/4245